Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Patient-tailored Cancer Immunotherapy Supported by a Multifaceted Predictive Signature Composed of Integrative Omics and Molecular Imaging

NCT04193956 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04193956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04193956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Patient-tailored Cancer Immunotherapy Supported by a Multifaceted Predictive Signature Composed of Integrative Omics and Molecular Imaging
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2018
Completion date
September 30, 2024
Enrollment
3,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, non-small cell lung cancer